Bodal Chemicals net profit surges 179% in Q1FY27 on strong volumes

3 min read     Updated on 05 Aug 2026, 08:33 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Bodal Chemicals delivered robust Q1FY27 results with standalone PAT rising 179% YoY to ₹287.83 million on 56% revenue growth. Segmental strength in Dye Intermediates (+44%) and Basic Chemicals (+89%) drove the top-line expansion. Consolidated PAT jumped to ₹303.79 million, supported by better demand allowing price pass-throughs and contributions from new benzene downstream products.

powered bylight_fuzz_icon
47486473

*this image is generated using AI for illustrative purposes only.

Bodal Chemicals reported a sharp acceleration in profitability for the quarter ended June 30, 2026 (Q1FY27), with standalone net profit after tax (PAT) surging 179% year-on-year to ₹287.83 million. This performance significantly outpaced the previous year’s figure of ₹103.42 million and was underpinned by a robust 56% year-on-year expansion in revenue from operations to ₹6,982.96 million. The strong bottom-line growth reflects improved operational efficiency and successful pass-through of higher raw material costs to finished goods, driven by better demand across its integrated chemical divisions.

The Board of Directors approved the unaudited financial results on August 5, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s. B N P S & Associates LLP, the Statutory Auditors of the Company, issued limited review reports for both standalone and consolidated results. Consolidated net profit also increased sharply to ₹303.79 million, up from ₹95.33 million in the prior year quarter, while consolidated revenue reached ₹7,090.41 million.

Financial Performance Highlights

Revenue from operations stood at ₹6,982.96 million for the quarter, compared to ₹5,770.99 million in the previous quarter and ₹4,448.47 million in the same quarter last year. Total income for the period reached ₹7,035.75 million. On the expense side, total expenses were recorded at ₹6,648.34 million, driven primarily by cost of materials consumed at ₹4,811.13 million and other expenses at ₹1,779.35 million. Profit before tax was ₹387.41 million, against which tax expense amounted to ₹99.58 million.

Metric Q1 FY27 (₹ Mn) Q4 FY26 (₹ Mn) Q1 FY26 (₹ Mn) YoY Change
Revenue from Operations 6,982.96 5,770.99 4,448.47 +56.9%
Total Income 7,035.75 5,789.61 4,470.91 +57.4%
Total Expenses 6,648.34 5,421.49 4,332.85 +53.5%
Profit Before Tax 387.41 368.12 138.06 +180.6%
Net Profit After Tax 287.83 305.24 103.42 +178.3%
EPS (Basic) ₹2.29 ₹2.43 ₹0.82 +179.3%

Consolidated EBITDA grew by 45% year-on-year to ₹751.00 million, although the EBITDA margin contracted slightly to 10.5% from 11.3% in Q1FY26, reflecting the impact of higher raw material costs linked to crude oil prices.

Segmental Growth Drivers

The investor presentation highlighted that the company’s integrated model and cascading effect resulted in better realization across divisions. Revenue from Dye Intermediates grew by 44% year-on-year to ₹2,166 million, driven by improved realization and volume. Dyestuff revenue grew by 23% year-on-year to ₹1,490 million, where improved realization helped absorb raw material pressure. Revenue from Basic Chemicals surged by 89% year-on-year to ₹839 million, mainly due to an increase in its main raw material, Sulphur. The Chlor Alkali business reported revenue of ₹870 million, a modest growth of 3% year-on-year.

Additionally, Saykha’s Benzene downstream division started contributing to the topline during the quarter, with management expecting gradual revenue growth from this segment. On the international front, Sener Boya, the Turkish subsidiary, reported revenue growth of 41% and a PAT of ₹22 million for Q1FY27. In contrast, the Chinese and Indonesian subsidiaries remained subdued during the quarter.

What the Numbers Show

The most notable aspect of this quarter’s performance is the disproportionate rise in profitability relative to revenue growth. While revenue increased by approximately 57% year-on-year, net profit surged by nearly 179%. This divergence suggests improved operational efficiency or margin expansion, despite the slight contraction in EBITDA margin. The recognition of ₹25.71 million in SGST incentive income under the Punjab Industrial Incentive Scheme contributed to revenue, subject to final verification by the competent authority. The company’s ability to pass on price effects due to better demand has been critical in maintaining margins amidst rising crude oil-linked raw material costs.

Key Disclosures and Notes

The financial results include the impact of Ind AS 29 – ‘Accounting of Hyperinflationary economies’ applied to subsidiaries in Turkey. A restatement impact of ₹13.10 million was debited to other expenses in the consolidated results for the quarter. The Group noted that four subsidiaries’ interim financial information had not been reviewed by their auditors but were deemed not material to the Group, with total income of ₹91.55 million and a net loss of ₹1.84 million. Two other subsidiaries’ results were reviewed by other auditors, reflecting total income of ₹73.57 million and net profit of ₹21.47 million.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE338D01028/906fc7b1-8a79-40c7-bf57-8c21f3dce537.pdf

Historical Stock Returns for Bodal Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.28%+10.36%+20.85%+45.44%+4.81%-36.47%

How sustainable is Bodal Chemicals' current pricing power if crude oil-linked raw material costs continue to rise in the coming quarters?

What specific operational strategies is management implementing to reverse the slight contraction in consolidated EBITDA margins observed in Q1FY27?

When does the company expect Saykha’s Benzene downstream division to become a material contributor to the group's overall profitability?

Bodal Chemicals promoters declare no encumbrance for FY26

1 min read     Updated on 16 Jun 2026, 02:11 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Bodal Chemicals Ltd disclosed that its promoters and promoter group did not create any encumbrance on their shares during the financial year ended March 31, 2026. The declaration, submitted under Regulation 31(4) of the SEBI Takeover Regulations 2011, was made by authorised person Suresh J. Patel on behalf of the group.

powered bylight_fuzz_icon
43101667

*this image is generated using AI for illustrative purposes only.

Bodal Chemicals Ltd has confirmed that its promoters and promoter group did not pledge or encumber their shares during the financial year ended March 31, 2026. The disclosure ensures that the shareholding structure of the key stakeholders remains free of any direct or indirect charges for the specified period.

The declaration was submitted by Suresh J. Patel, an authorised representative acting on behalf of the promoters and promoter group, in compliance with Regulation 31(4) of the SEBI Takeover Regulations 2011. The filing was addressed to the stock exchanges, BSE Ltd and National Stock Exchange of India Ltd, on April 04, 2026.

The document identifies eight individuals as part of the promoter and promoter group. Suresh J. Patel is listed as a Promoter, while the remaining members are classified under the Promoter Group.

Promoter and Promoter Group Details

The following table outlines the individuals comprising the promoter and promoter group of Bodal Chemicals as per the annexure provided in the filing:

Name(s) of the person and persons Acting in concert (PAC) Belongs to promoter/promoter group
Mr. Suresh J. Patel Promoter
Mr. Bhavin S. Patel Promoter Group
Mr. Ankit S. Patel Promoter Group
Mrs. Meena S. Patel Promoter Group
Mr. Bansi M. Patel Promoter Group
Mr. Rakesh R. Patel Promoter Group
Mrs. Shakuntala J. Patel Promoter Group
Mr. Ramesh D. Patel Promoter Group

A copy of the declaration was also forwarded to the Chairman and members of the Audit Committee of Bodal Chemicals Limited for their records.

Historical Stock Returns for Bodal Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.28%+10.36%+20.85%+45.44%+4.81%-36.47%

How might the absence of share pledging influence investor confidence and stock liquidity in the upcoming quarters?

What are Bodal Chemicals' strategic capital allocation plans given the promoters' unencumbered holding status?

Could this clean shareholding structure signal potential for future acquisitions or expansion initiatives?

More News on Bodal Chemicals

1 Year Returns:+4.81%